Johnson & Johnson (JNJ)VP Corporate Controller sold ~$1.16M

~$1.16M

Approx. value · 6,999 sh @ $165.88

21K

Holds after · shares reported

Traded

Feb 25, 2025

Filed

Feb 26, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 6, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Dec 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Dec 12, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
4. Dec 24, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
5. Dec 31, 2024CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
6. Jan 8, 2025Congress · 1 personMembers of Congress: 4 purchases
7. Jan 16, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
8. Jan 21, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
9. Jan 24, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
10. Feb 7, 2025InsiderCFO sold ~$2M of JNJ shares in the open market
11. Feb 18, 2025InsiderChair sold ~$63K of JNJ shares in the open market
12. Feb 24, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
13. Feb 25, 2025 · this disclosureInsiderOfficer sold ~$1.16M of JNJ shares in the open market

What came next

1. Mar 3, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Mar 4, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Mar 5, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
4. Mar 7, 2025FDARecall: PDS¿PLUS¿VIO¿30IN(75CM)¿USP6-0(M0.7)¿D/A¿C-1¿MP
5. Mar 7, 2025FDARecall: PROLENE BLU 18IN(45CM) USP6-0(M0.7) S/A P-1 PRM
6. Mar 7, 2025FDARecall: ETHIBOND EXCEL GRN 36IN(90CM) USP2-0(M3) D/A MH
7. Mar 7, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
8. Mar 20, 2025FDAFDA drug approval: Tremfya
9. Mar 21, 2025FDAFDA drug approval: Prezcobix
10. Mar 24, 2025CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
11. Mar 28, 2025FDAFDA device clearance: Synthes Graphic Case & Tray System
12. Mar 31, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
13. Apr 1, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
14. Apr 8, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
15. Apr 9, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
16. Apr 10, 2025FDAFDA drug approval: Darzalex
17. Apr 21, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
18. Apr 22, 2025FDARecall: Endopath Echelon Vascular White Reload for Advanced Placement Tip (35mm, 4 row); Product code VASECR35
19. Apr 24, 2025FDAFDA device clearance: MENTOR™ PliaForm™ Breast Tissue Expander w/ Suture Tabs
20. Apr 29, 2025FDAFDA drug approval: Imaavy

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Robert J Decker, VP Corporate Controller

• SEC Form 4 at Johnson & Johnson (JNJ)Mar 3, 2026

The full history of Robert J Decker, VP Corporate Controller is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026
• Senate eFD periodic transaction reportSep 11, 2026

Everything OQRO holds on this company is on its JNJ page.